As of 2025-07-16, the Fair Value of Predictive Oncology Inc (POAI) is -6.10 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.79 USD, the upside of Predictive Oncology Inc is -871.23%.
With the market price of 0.79 USD and our fair value calculation, Predictive Oncology Inc (POAI) is not a good investment. Investing in POAI stocks now will result in a potential loss of 871.23%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -25.88 | -19.66 | -25.74 | -13.98 | -12.66 | -19.59 |
| YoY growth | -33.47% | 24.03% | -30.93% | 45.67% | 9.44% | 2.95% |
| Market Cap (mil) | 7.06 |
| P/E | |
| Forward P/E |
| EPS | -1.22 |
| Avg earnings growth rate | 2.95% |
| TTM earnings | -10.89 |